Health Related Quality of Life of Rosacea Patients in China Assessed by Dermatology Life Quality Index and Willingness to Pay
March 2022
in “
Patient Preference and Adherence
”
TLDR Rosacea severely affects the quality of life for many patients in China, especially young adults and those with appearance-related jobs.
This study evaluated the health-related quality of life (HRQoL) of 921 rosacea patients in China using the Dermatology Life Quality Index (DLQI) and willingness to pay (WTP) metrics. The mean DLQI score was 11.6, indicating a significant impact on quality of life, particularly in work/school and self-consciousness. Factors such as age, gender, occupational appearance requirements, and symptom severity were significantly associated with DLQI scores. Patients were willing to pay an average of €106.5 monthly or €896.2 for a complete cure, with higher DLQI scores correlating with higher WTP. The study highlighted the substantial psychosocial burden of rosacea and emphasized the importance of considering HRQoL in treatment strategies.